WA melanoma research featured at global Oncology congress
By Richard Schoonraad | Cancer, Cancer, Immunotherapy, Liver Cancer, Media Releases, Melanoma, Melanoma Discovery, Melonoma, News & Events, Research, Translation, TumoursBreakthrough research from the Harry Perkins Institute of Medical Research that explores possible new treatments for melanoma will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting.…
3D Printed heart valves to be commercialised
By Richard Schoonraad | Biomedical engineering, Cardiovascular Disease, Cardiovascular Disease, Heart, Media Releases, News & Events, T3mPLATE Laboratory, Vascular EngineeringCutting-edge biopolymer 3D-printed heart valve technology to be commercialised in Australia to help millions globally suffering from aortic stenosis. CUREator, Australia’s national biotech incubator, funds Western Australian biomedical engineering and…
Antibiotics resistance solution to be commercialised
By Richard Schoonraad | Bacteria, Cardiovascular Science and Diabetes Program, Emergency Medicine, Kidney Disease, Media Releases, News & Events, Synthetic Biology and Drug Discovery, Targeted Drug Delivery, TranslationBreakthrough diagnostic technology to be commercialised in Australia in race to save millions globally from antibiotic resistant sepsis. CUREator funds Western Australian research team to develop life-saving technology through the…

Further mysteries of cardiovascular disease-causing plaque revealed
By Richard Schoonraad | Blood Vessels, Cardiovascular Disease, Cardiovascular Disease, Cardiovascular Science and Diabetes Program, Heart, Media Releases, News & Events, ResearchNew discoveries on where plaque can form and what can trigger a heart attack. Researchers from the Harry Perkins Institute of Medical Research have published new findings that turn the…
$5m funding awarded to researchers for inherited disease hunt
By Richard Schoonraad | Funding, Genes, Genetic Disease, Genetic Disease, Genetics, Media Releases, News & Events, Other Genetic Disorders, ResearchNational approach to finding the causes of several debilitating diseases Medical Research Future Fund awards $4,877,532 over 5 years to ‘The missing heritability of human disease: discovery to implementation’. Blood…
New liver cancer blood test gets $2.5m research funding boost
By Richard Schoonraad | Bioimaging Research and Innovation for Translational Engingeering BRITE, Cancer, Cancer, Cancer Epigenetics, Cell Signalling, Cell-To-Cell Communication, Functional Genomics, Genes, Media Releases, News & Events, Single CellPredicting relapse for one of the world's deadliest cancers. Perth cancer researchers are on track to improve the outcomes of patients with the most common type of primary liver cancer.…
ACRF Centre for Advanced Cancer Genomics opens in Perth
By Richard Schoonraad | Bioimaging Research and Innovation for Translational Engingeering BRITE, Cancer, Cancer, Cancer Epigenetics, Cell Signalling, Cell-To-Cell Communication, Functional Genomics, Genes, Media Releases, News & Events, Single CellLatest technology analyses WA cancer patient tumours. The Australian Cancer Research Foundation (ACRF) Centre for Advanced Cancer Genomics, housing the next generation DNA sequencing technology, was opened today at the…
New gene discovery published in New England Journal of Medicine
By Richard Schoonraad | Epigenetics and Genomics Laboratory, Genetic Disease, Genetic Disease, Genetics, News & Events, ResearchDisease-causing genetic mutation finding to impact thousands of patients world-wide The genetic cause of a brain disease that leads to vertigo, speech difficulties and loss of coordination, and which can…